Biohaven Working Capital Growth & History (BHVN)
Biohaven's working capital was $252.4M for fiscal 2025.
View full Biohaven company overviewBiohaven annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $252.4M | −$131.9M | −34.31% |
| 2024 | 2024-12-31 | $384.2M | −$2.8M | −0.72% |
| 2023 | 2023-12-31 | $387.0M | −$109.9M | −22.12% |
| 2022 | 2022-12-31 | $496.9M | $444.1M | +839.62% |
| 2021 | 2021-12-31 | $52.9M | — | — |
Biohaven quarterly working capital
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $233.9M | −$116.6M | −33.27% |
| Q1 2026 | 2026-03-31 | $333.6M | $114.9M | +52.51% |
| Q4 2025 | 2025-12-31 | $252.4M | −$131.9M | −34.31% |
| Q3 2025 | 2025-09-30 | $210.6M | −$77.6M | −26.93% |
| Q2 2025 | 2025-06-30 | $350.5M | −$4.6M | −1.28% |
| Q1 2025 | 2025-03-31 | $218.7M | −$43.4M | −16.57% |
| Q4 2024 | 2024-12-31 | $384.2M | −$2.8M | −0.72% |
| Q3 2024 | 2024-09-30 | $288.2M | $39.8M | +16.03% |
| Q2 2024 | 2024-06-30 | $355.1M | $8.8M | +2.54% |
| Q1 2024 | 2024-03-31 | $262.2M | −$168.3M | −39.10% |
| Q4 2023 | 2023-12-31 | $387.0M | −$109.9M | −22.12% |
| Q3 2023 | 2023-09-30 | $248.4M | $196.3M | +376.62% |
| Q2 2023 | 2023-06-30 | $346.3M | — | — |
| Q1 2023 | 2023-03-31 | $430.5M | — | — |
| Q4 2022 | 2022-12-31 | $496.9M | $444.1M | +839.62% |
| Q3 2022 | 2022-09-30 | $52.1M | — | — |
| Q4 2021 | 2021-12-31 | $52.9M | — | — |
Biohaven working capital trends
Between the periods ended 2021-12-31 and 2025-12-31, Biohaven's working capital increased from $52.9M to $252.4M, a change of $199.5M. The latest reported quarter, Q2 2026, shows $233.9M.
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗Community posts
FDA accepts Biohaven's resubmitted application for spinocerebellar ataxia drug
Biohaven ($BHVN) said the FDA accepted its resubmitted application for Vyglxia, the proposed brand for troriluzole, to treat spinocerebellar ataxia. The submission includes additional supportive analyses and was deemed a complete response t ...